Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Truvada with Proteus Sensor System
NCT02968576Completed
- Sponsor
- University of Colorado Denver
- Start
- Dec 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of Colorado Denver. Primary endpoints: Peak Plasma Concentration at 96 hours and Area Under the Concentration-time Curve at 96 hours. Started Dec 2016; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02968576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968576.